__timestamp | Evotec SE | Sarepta Therapeutics, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 89496000 | 9757000 |
Thursday, January 1, 2015 | 127677000 | 1253000 |
Friday, January 1, 2016 | 164507000 | 5421000 |
Sunday, January 1, 2017 | 257630000 | 154584000 |
Monday, January 1, 2018 | 375405000 | 301034000 |
Tuesday, January 1, 2019 | 446437000 | 380833000 |
Wednesday, January 1, 2020 | 500924000 | 540099000 |
Friday, January 1, 2021 | 618034000 | 701887000 |
Saturday, January 1, 2022 | 751448000 | 933013000 |
Sunday, January 1, 2023 | 781426000 | 1243336000 |
Data in motion
In the competitive world of biotechnology, revenue growth is a key indicator of success. Over the past decade, Sarepta Therapeutics, Inc. and Evotec SE have been neck and neck in their quest for financial dominance. Starting in 2014, Evotec SE led the race with a revenue of approximately $89 million, while Sarepta trailed with just under $10 million. However, the tables turned dramatically by 2023, with Sarepta's revenue surging to over $1.2 billion, a staggering increase of over 12,000%. Meanwhile, Evotec SE also experienced impressive growth, reaching nearly $781 million, marking an increase of over 770% from its 2014 figures. This remarkable growth trajectory highlights the dynamic nature of the biotech industry and the relentless pursuit of innovation and market expansion by these two companies.
Revenue Showdown: Eli Lilly and Company vs Sarepta Therapeutics, Inc.
Dr. Reddy's Laboratories Limited or Sarepta Therapeutics, Inc.: Who Leads in Yearly Revenue?
Breaking Down Revenue Trends: Dr. Reddy's Laboratories Limited vs Evotec SE
Revenue Insights: Bio-Techne Corporation and Evotec SE Performance Compared
Sarepta Therapeutics, Inc. vs Walgreens Boots Alliance, Inc.: Annual Revenue Growth Compared
Revenue Insights: Sarepta Therapeutics, Inc. and Exelixis, Inc. Performance Compared
Breaking Down Revenue Trends: Sarepta Therapeutics, Inc. vs Jazz Pharmaceuticals plc
Sarepta Therapeutics, Inc. vs Mesoblast Limited: Annual Revenue Growth Compared
Revenue Insights: Sarepta Therapeutics, Inc. and Travere Therapeutics, Inc. Performance Compared
Comparing Revenue Performance: Sarepta Therapeutics, Inc. or Galapagos NV?
Comparing Revenue Performance: Grifols, S.A. or Evotec SE?
Revenue Insights: Amneal Pharmaceuticals, Inc. and Evotec SE Performance Compared